Showing results (91-100 of 199) with videos related to

Sort By:
Pageof 20
Patient Preference and Adherence|May 19, 2021
Lower Patient Anxiety and Unchanged Levels of Adherence to Hemato-Oncologic Treatment in Response to New Measures to Reduce Hospital Exposure Risk to COVID-19Nadav Sarid, Shir Mann, Yair Herishanu, et al.
Haematologica|February 4, 2017
Lymphocyte activation gene 3: a novel therapeutic target in chronic lymphocytic leukemiaMika Shapiro, Yair Herishanu, Ben-Zion Katz, et al.
Acta Haematologica|October 2, 2024
Belantamab Mafodotin in Relapsed/Refractory AL Amyloidosis: Real-World Multi-Center Experience and Review of the LiteratureEyal Lebel, Vladimir Vainstein, Paolo Milani, et al.
Cancer|January 19, 2012
A randomized study comparing yttrium-90 ibritumomab tiuxetan (Zevalin) and high-dose BEAM chemotherapy versus BEAM alone as the conditioning regimen before autologous stem cell transplantation in patients with aggressive lymphomaAvichai Shimoni, Irit Avivi, Jacob M Rowe, et al.
Annals of Hematology|August 30, 2023
Management and outcome of 500 multiple myeloma patients treated for first relapse outside clinical studiesIrit Avivi, Naama Yekutiel, Tamir Shragai, et al.
Medicine|March 6, 2016
The Value of PET/CT in Detecting Bone Marrow Involvement in Patients With Follicular LymphomaChava Perry, Hedva Lerman, Erel Joffe, et al.
The Journal of Pathology|April 3, 2016
Bortezomib-induced pro-inflammatory macrophages as a potential factor limiting anti-tumour efficacyOfrat Beyar-Katz, Ksenia Magidey, Neta Ben-Tsedek, et al.
Cancers|December 9, 2023
The Clinical Significance of Circulating Lymphocytes Morphology in Diffuse Large B-Cell Lymphoma As Determined by a Novel, Highly Sensitive MicroscopyGil Fridberg, Galit Horn, Anat Globerson Levin, et al.
Human Gene Therapy|September 8, 2021
Extracellular Vesicles Derived from Chimeric Antigen Receptor-T Cells: A Potential Therapy for CancerAnat Aharon, Galit Horn, Tali Hana Bar-Lev, et al.
European Journal of Haematology|June 30, 2018
Can bone marrow cellularity help in predicting prognosis in myelodysplastic syndromes?Uri Greenbaum, Erel Joffe, Kalman Filanovsky, et al.
Pageof 20